Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired PepGen Inc. securities between March 7, 2024 and March 3, 2025. PepGen is a ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, ...

The evidence successfully confiscated was 30.5 kilogrammes of pangolin scales, which were believed to have been gathered from ...

Amidst a backdrop of fluctuating market sentiment, the S&P 500 and Nasdaq Composite have shown resilience by rebounding from early losses, driven by investor optimism around trade negotiations and ...

If slashed ticket prices, closed stadium sections and moved seats are any indication, fans aren’t exactly clamoring to attend the Club World Cup. The tournament opens Saturday with Lionel ...

Key Takeaways AI accelerates drug approvals in 2025 by streamlining clinical data analysis.Advanced AI tools reduce costs and time for new medicine development.

Edinburgh to host UK’s $956 million national supercomputer, powering breakthroughs in AI, medicine, and climate science.